000			02022cam a22004817i 4500
001			19883965
003			OSt
005			20240305192053.0
008			170810t20172017enka b 001 0 eng d
010			_a 2016499987
020			_a9781782624240 (hardback)
020			_a1782624244 (hardback)
020			_z9781782629870 (PDF)
020			_z9781788011495 (EPUB)
035			_a(OCoLC)ocn967973670
040			_aBTCTA _beng _cBTCTA _erda _dBDX _dYDX _dOCLCO _dCDX _dOCLCO _dOCLCF _dDLC
042			_alccopycat
050	0	0	_aRM267 _b.A493 2017
060		4	_aQV 745
082	0	4	_a615.3/29 _223
245	0	0	_aAntibiotic drug discovery : _bnew targets and molecular entities / _cedited by Steven M. Firestine, Wayne State University, Detroit, USA, and Troy Lister, Spero Therapeutics, Cambridge, USA.
264		1	_aLondon : _bRoyal Society of Chemistry, _c[2017]
264		4	_c©2017
300			_axv, 271 pages : _billustrations (some color) ; _c24 cm.
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
490	1		_aDrug discovery ; _v58
504			_aIncludes bibliographical references and index.
520			_aThis book identifies and elaborates the most recent and compelling strategies for antibiotic drug discovery with a primary focus on new targets, mechanisms and molecular entities.-- _cSource other than Library of Congress.
650		0	_aAntibiotics _xResearch. _916141
650		2	_aDrug Discovery. _911882
650		7	_aAntibiotics _xResearch. _2fast _0(OCoLC)fst00810432 _916141
700	1		_aFirestine, Steven M., _eeditor. _916142
700	1		_aLister, Troy, _eeditor. _916143
700	1		_aLazarides, Linos, _eauthor. _916144
700	1		_aAbel-Santos, Ernesto, _eauthor. _916145
700	1		_aRotella, David P., _eeditor. _4edt _916146
830		0	_aRSC drug discovery series ; _v58. _916147
906			_a7 _bcbc _ccopycat _d2 _encip _f20 _gy-gencatlg
942			_2ddc _cEB
999			_c898 _d898